Predict your next investment

Seaside Therapeutics company logo
HEALTHCARE | Drug Development
seasidetherapeutics.com

See what CB Insights has to offer

Stage

Series C | Alive

Total Raised

$30M

Last Raised

$30M | 12 yrs ago

About Seaside Therapeutics

Seaside Therapeutics is creating new drug treatments to correct or improve the course of Fragile X Syndrome, autism and other disorders of brain development.

Seaside Therapeutics Headquarter Location

700 Technology Sq

Cambridge, Massachusetts, 02139,

United States

617-374-9009

Latest Seaside Therapeutics News

Fragile X Syndrome Global Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Seaside Therapeutics, Novartis, Alcobra - Research and Markets

Jun 8, 2016

Fragile X Syndrome Global Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Seaside Therapeutics, Novartis, Alcobra - Research and Markets June 08, 2016 07:12 AM Eastern Daylight Time DUBLIN--( BUSINESS WIRE )--Research and Markets has announced the addition of the "Fragile X Syndrome Global Clinical Trials Review, H1, 2016" clinical trials to their offering. The clinical trial report, Fragile X Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Fragile X Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Fragile X Syndrome. It includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Scope: The report provides a snapshot of the global clinical trials landscape The report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The report provides enrollment trends for the past five years Reasons to Buy: Assists in formulating key business strategies with regards to investment Helps in identifying prominent locations for conducting clinical trials which saves time and cost Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities Supports understanding of trials count and enrollment trends by country in global therapeutics market Facilitates clinical trial assessment of the indication on a global, regional and country level Companies Mentioned:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Seaside Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Seaside Therapeutics is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

14,140 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Seaside Therapeutics Patents

Seaside Therapeutics has filed 4 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/7/2013

6/2/2015

Syndromes, Rare diseases, Sedatives, Calcium channel blockers, Lactams

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

6/7/2013

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/2/2015

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Syndromes, Rare diseases, Sedatives, Calcium channel blockers, Lactams

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.